Hims & Hers Health, Inc.

NYSE:HIMS 株式レポート

時価総額:US$5.5b

Hims & Hers Health マネジメント

マネジメント 基準チェック /24

Hims & Hers Healthの CEO はAndrew Dudumで、 Jan2017年に任命され、 の在任期間は 7.83年です。 の年間総報酬は$ 14.40Mで、 4.2%給与と95.8%のボーナス(会社の株式とオプションを含む)で構成されています。 は、会社の株式の8.61%を直接所有しており、その価値は$ 476.70M 。経営陣と取締役会の平均在任期間はそれぞれ2.7年と2.9年です。

主要情報

Andrew Dudum

最高経営責任者

US$14.4m

報酬総額

CEO給与比率4.2%
CEO在任期間7.8yrs
CEOの所有権8.6%
経営陣の平均在職期間2.7yrs
取締役会の平均在任期間2.9yrs

経営陣の近況

Recent updates

Hims & Hers Health: The Amazon Curse Is Being Overstated

Nov 15

Hims & Hers: A Lot More Than Just GLP-1, And It's Proving Its Ability To Grow

Nov 05

HIMS: GLP-1 Is Just The Beginning

Oct 17

Hims & Hers: Shortage Saga Brings Stupendous Risk-Reward

Oct 03

Hims & Hers Health, Inc.'s (NYSE:HIMS) P/S Is Still On The Mark Following 25% Share Price Bounce

Oct 01
Hims & Hers Health, Inc.'s (NYSE:HIMS) P/S Is Still On The Mark Following 25% Share Price Bounce

Hims & Hers Is Unbelievably Cheap And Profitable: Buy Now

Sep 24

Hims & Hers Health Post Q2 Earnings - Compounded GLP-1 Ploy Faces New Threats (Rating Downgrade)

Aug 27

Hims & Hers: Digesting Q2 2024 Earnings, Shares Still Undervalued, Rating Downgrade

Aug 20

Hims & Hers Health, Inc.'s (NYSE:HIMS) Share Price Is Still Matching Investor Opinion Despite 27% Slump

Aug 11
Hims & Hers Health, Inc.'s (NYSE:HIMS) Share Price Is Still Matching Investor Opinion Despite 27% Slump

Hims & Hers Health: Buy The Dip, With Or Without The GLP-1 Shortage

Aug 07

Hims & Hers: The Thesis Goes Far Beyond GLP-1

Jul 18

Hims & Hers: Buy The Dip To Catch The Next Rip

Jun 24

Why Investors Shouldn't Be Surprised By Hims & Hers Health, Inc.'s (NYSE:HIMS) 70% Share Price Surge

Jun 19
Why Investors Shouldn't Be Surprised By Hims & Hers Health, Inc.'s (NYSE:HIMS) 70% Share Price Surge

Hims & Hers: The Undervalued Gem Poised For Growth

Jun 18

Beyond The Marketing Machine: Why Hims & Hers Stock Might Be Vulnerable

Jun 10

Hims & Hers Health, Inc.'s (NYSE:HIMS) CEO Compensation Is Looking A Bit Stretched At The Moment

May 31
Hims & Hers Health, Inc.'s (NYSE:HIMS) CEO Compensation Is Looking A Bit Stretched At The Moment

Hims & Hers: Soaring On Access To Compounded GLP-1 Drugs, Further Volatility Ahead

May 21

Hims & Hers Health: An Unforced Error

May 06

Hims & Hers Health, Inc. (NYSE:HIMS) Stocks Pounded By 27% But Not Lagging Industry On Growth Or Pricing

May 04
Hims & Hers Health, Inc. (NYSE:HIMS) Stocks Pounded By 27% But Not Lagging Industry On Growth Or Pricing

Hims & Hers Health: Becoming A Market Leader Within The Growing Digital Health Industry

Apr 24

Hims & Hers Health: Strong Prospects But Weak Business Model Consolidation

Apr 05

Hims & Hers: 5 Reasons Why This Is A Phenomenal Long-Term Growth Stock

Mar 21

Pills Pay The Bills: Mini Deep Dive On Hims & Hers Health

Mar 12

Investors Appear Satisfied With Hims & Hers Health, Inc.'s (NYSE:HIMS) Prospects As Shares Rocket 49%

Feb 28
Investors Appear Satisfied With Hims & Hers Health, Inc.'s (NYSE:HIMS) Prospects As Shares Rocket 49%

Hims & Hers: Turning The Profitability Corner And Returning 28%

Feb 25

Hims & Hers Health: No Clear Moat Besides First Mover Advantage

Jan 23

Hims & Hers Health: Unleashing Macro Momentum - Investing In Growth At A Higher Multiple

Jan 10

Investors Still Waiting For A Pull Back In Hims & Hers Health, Inc. (NYSE:HIMS)

Jan 07
Investors Still Waiting For A Pull Back In Hims & Hers Health, Inc. (NYSE:HIMS)

Hims & Hers Health Q3: The Cheapest Growth Stock Around

Dec 14

Hims & Hers Health: What Would The Author Of 100 Baggers Say?

Nov 30

Hims & Hers: The Most Undervalued Small Cap Stock I See

Nov 08

Hims & Hers: A Promising Company With Resolvable Challenges

Nov 02

Hims & Hers: Specialization Is The Secret To Great Growth

Oct 25

Hims & Hers Health: Can't Get Much Better

Sep 25

CEO報酬分析

Hims & Hers Health の収益と比較して、Andrew Dudum の報酬はどのように変化したか?
日付総報酬給与会社業績
Sep 30 2024n/an/a

US$101m

Jun 30 2024n/an/a

US$18m

Mar 31 2024n/an/a

-US$2m

Dec 31 2023US$14mUS$612k

-US$24m

Sep 30 2023n/an/a

-US$36m

Jun 30 2023n/an/a

-US$47m

Mar 31 2023n/an/a

-US$59m

Dec 31 2022US$11mUS$600k

-US$66m

Sep 30 2022n/an/a

-US$86m

Jun 30 2022n/an/a

-US$83m

Mar 31 2022n/an/a

-US$73m

Dec 31 2021US$15mUS$574k

-US$108m

Sep 30 2021n/an/a

-US$82m

Jun 30 2021n/an/a

-US$72m

Mar 31 2021n/an/a

-US$63m

Dec 31 2020US$27mUS$527k

-US$18m

Sep 30 2020n/an/a

-US$25m

Jun 30 2020n/an/a

-US$38m

Mar 31 2020n/an/a

-US$58m

Dec 31 2019US$254kUS$254k

-US$72m

報酬と市場: Andrewの 総報酬 ($USD 14.40M ) は、 US市場 ($USD 7.74M ) の同規模の企業の平均を上回っています。

報酬と収益: Andrewの報酬は、過去 1 年間の会社の業績と一致しています。


CEO(最高経営責任者

Andrew Dudum (35 yo)

7.8yrs

在職期間

US$14,401,411

報酬

Mr. Andrew Dudum serves as Chairman of the Board and serves as Chief Executive Officer at Hims & Hers Health, Inc. since January 20, 2021. He Co-Founded Hims & Hers Health, Inc. in 2017. He is Co-founded H...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Andrew Dudum
Co-Founder7.8yrsUS$14.40m8.61%
$ 476.7m
Yemi Okupe
Chief Financial Officer2.8yrsUS$7.43m0.051%
$ 2.8m
Melissa Baird
Chief Operating Officer3.8yrsUS$6.77m0.29%
$ 16.0m
Soleil Boughton
Chief Legal Officer & Corporate Secretary3.8yrsUS$5.21m0.077%
$ 4.2m
Patrick Carroll
Chief Medical Officer1.9yrsUS$198.26k0.088%
$ 4.9m
Mike Chi
Chief Commercial Officerless than a yearUS$6.71m0.084%
$ 4.7m
Irene Becklund
Senior VP5.4yrsUS$961.12k0.0023%
$ 129.5k
Khobi Brooklyn
Chief Communications Officer1.1yrsデータなしデータなし
Amee Parekh
Senior Vice President of Human Resources2.7yrsデータなしデータなし
Peter Stahl
Senior VP & Member of Medical Advisory Boardno dataデータなしデータなし
Scott Knoer
Chief Pharmacy & Innovation Officer1.9yrsデータなしデータなし
Daniel Lieberman
Senior Vice President of Mental Health1.7yrsデータなしデータなし

2.7yrs

平均在職期間

44yo

平均年齢

経験豊富な経営陣: HIMSの経営陣は 経験豊富 であると考えられます ( 2.7年の平均在職年数)。


取締役

名称ポジション在職期間報酬所有権
Andrew Dudum
Co-Founder3.8yrsUS$14.40m8.61%
$ 476.7m
Patrick Carroll
Chief Medical Officer2.8yrsUS$198.26k0.088%
$ 4.9m
Peter Stahl
Senior VP & Member of Medical Advisory Board2.8yrsデータなしデータなし
Delos Cosgrove
Independent Director4.2yrsUS$194.26k0.025%
$ 1.4m
David Wells
Lead Independent Director4.2yrsUS$227.41k0.071%
$ 4.0m
Andrea Perez Garcia
Independent Director3.7yrsUS$205.51k0.033%
$ 1.8m
Amy Voedisch
Member of Medical Advisory Board2.9yrsデータなしデータなし
Lawrence Jenkins
Member of Medical Advisory Boardno dataデータなしデータなし
Bertha Chen
Member of Medical Advisory Board2.9yrsデータなしデータなし
Denise Asafu-Adjei
Member of Medical Advisory Board2.9yrsデータなしデータなし
Stanton Honig
Member of Medical Advisory Board2.9yrsデータなしデータなし
Stanley Althof
Member of Medical Advisory Board2.9yrsデータなしデータなし

2.9yrs

平均在職期間

53yo

平均年齢

経験豊富なボード: HIMSの 取締役会経験豊富 ではない ( 2.9年の平均在任期間) ため、新しい取締役会が必要であると考えられます。